{
  "id": "cisplatin_aki",
  "title": "Cisplatin-Associated Acute Kidney Injury (CP-AKI) Risk Calculator",
  "description": "Predicts the risk of acute kidney injury in patients treated with intravenous cisplatin. This calculator estimates the probability of moderate to severe AKI (≥2-fold rise in serum creatinine or need for kidney replacement therapy within 14 days of cisplatin administration).",
  "category": "nephrology",
  "version": "2024",
  "parameters": [
    {
      "name": "age",
      "type": "integer",
      "required": true,
      "description": "Patient age in years",
      "validation": {
        "min": 18,
        "max": 110
      },
      "unit": "years"
    },
    {
      "name": "hypertension",
      "type": "string",
      "required": true,
      "description": "History of hypertension",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "diabetes",
      "type": "string",
      "required": true,
      "description": "History of type 2 diabetes mellitus",
      "options": ["yes", "no"],
      "validation": {
        "enum": ["yes", "no"]
      }
    },
    {
      "name": "cisplatin_dose",
      "type": "float",
      "required": true,
      "description": "Total cisplatin dose",
      "validation": {
        "min": 1,
        "max": 1000
      },
      "unit": "mg"
    },
    {
      "name": "hemoglobin",
      "type": "float",
      "required": true,
      "description": "Hemoglobin level",
      "validation": {
        "min": 2.0,
        "max": 20.0
      },
      "unit": "g/dL"
    },
    {
      "name": "wbc_count",
      "type": "float",
      "required": true,
      "description": "White blood cell count",
      "validation": {
        "min": 1.0,
        "max": 300.0
      },
      "unit": "×10³/µL"
    },
    {
      "name": "platelet_count",
      "type": "float",
      "required": true,
      "description": "Platelet count",
      "validation": {
        "min": 1,
        "max": 1500
      },
      "unit": "×10³/µL"
    },
    {
      "name": "albumin",
      "type": "float",
      "required": true,
      "description": "Serum albumin level",
      "validation": {
        "min": 0.5,
        "max": 8.0
      },
      "unit": "g/dL"
    },
    {
      "name": "magnesium",
      "type": "float",
      "required": true,
      "description": "Serum magnesium level",
      "validation": {
        "min": 0.5,
        "max": 5.0
      },
      "unit": "mg/dL"
    }
  ],
  "result": {
    "name": "cp_aki_risk",
    "type": "float",
    "unit": "%",
    "description": "Estimated risk of moderate to severe acute kidney injury"
  },
  "interpretation": {
    "ranges": [
      {
        "min": 0,
        "max": 5,
        "risk_category": "Low",
        "description": "Low risk",
        "interpretation": "Low risk of cisplatin-associated acute kidney injury (< 5%). Standard monitoring may be appropriate. Consider baseline and follow-up creatinine measurements."
      },
      {
        "min": 5,
        "max": 15,
        "risk_category": "Moderate",
        "description": "Moderate risk",
        "interpretation": "Moderate risk of cisplatin-associated acute kidney injury (5-15%). Enhanced monitoring recommended. Consider prophylactic measures such as aggressive hydration and electrolyte repletion."
      },
      {
        "min": 15,
        "max": 30,
        "risk_category": "High",
        "description": "High risk",
        "interpretation": "High risk of cisplatin-associated acute kidney injury (15-30%). Close monitoring essential. Consider dose modification, alternative chemotherapy regimens, or nephrology consultation."
      },
      {
        "min": 30,
        "max": 100,
        "risk_category": "Very High",
        "description": "Very high risk",
        "interpretation": "Very high risk of cisplatin-associated acute kidney injury (≥30%). Strong consideration should be given to alternative treatment options. If cisplatin is necessary, intensive monitoring and prophylactic measures are mandatory. Nephrology consultation strongly recommended."
      }
    ]
  },
  "references": [
    "Gupta S, Portales-Castillo I, Daher A, Kitchlu A. Derivation and external validation of a simple risk score for predicting severe acute kidney injury after intravenous cisplatin: cohort study. BMJ. 2024 Mar 27;384:e077169. doi: 10.1136/bmj-2023-077169.",
    "Motwani SS, McMahon GM, Humphreys BD, Partridge AH, Waikar SS, Curhan GC. Development and Validation of a Risk Prediction Model for Acute Kidney Injury After the First Course of Cisplatin. J Clin Oncol. 2018 Mar 1;36(7):682-688. doi: 10.1200/JCO.2017.75.7161."
  ],
  "formula": "Risk (%) = 1 / (1 + e^(-X)) × 100, where X is calculated using patient characteristics including age, comorbidities, and laboratory values",
  "notes": [
    "This calculator predicts moderate to severe AKI, defined as ≥2-fold rise in serum creatinine or need for kidney replacement therapy within 14 days",
    "Derived from a cohort of 24,717 patients across 6 US academic cancer centers (2006-2022)",
    "Model achieved c-statistic of 0.75, outperforming previous risk models",
    "Risk calculator available at https://kidneycalc.org/cp-aki-calculator/",
    "Consider alternative chemotherapy regimens in high-risk patients"
  ]
}